Feb 24, 2026 07:30AM
Feb 19, 2026 05:30AM
Jan 12, 2026 07:34AM
Jan 12, 2026 07:30AM
Oct 28, 2025 07:30AM
Oct 17, 2025 08:00AM
Oct 17, 2025 08:00AM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis
Jul 29, 2025 07:30AM
Apr 29, 2025 07:30AM
Feb 25, 2025 07:30AM
Feb 25, 2025 07:29AM
Feb 25, 2025 07:29AM
Jan 13, 2025 08:48AM
Jan 13, 2025 07:31AM Kiniksa Pharmaceuticals (KNSA) Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
Jan 13, 2025 07:30AM
Oct 29, 2024 07:30AM
Jul 23, 2024 07:30AM
Jul 9, 2024 08:00AM
Apr 23, 2024 07:30AM
Apr 2, 2024 07:31AM
Apr 2, 2024 07:30AM Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
Feb 28, 2024 07:30AM
Jan 4, 2024 07:34AM
Jan 4, 2024 07:30AM
Oct 31, 2023 07:30AM
Jul 25, 2023 07:30AM
May 2, 2023 07:30AM
Feb 28, 2023 08:00AM Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution
Jan 9, 2023 08:00AM
Nov 1, 2022 08:00AM
Aug 3, 2022 07:30AM
May 3, 2022 08:00AM
Feb 22, 2022 08:00AM
Feb 22, 2022 07:59AM
Feb 22, 2022 07:59AM Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
Jan 10, 2022 08:00AM
Dec 28, 2021 06:59AM
Dec 28, 2021 06:59AM
Nov 1, 2021 08:00AM
Aug 16, 2021 08:00AM
Aug 3, 2021 08:00AM
Jun 9, 2021 09:27AM Pre-Open Stock Movers 06/09: (AEMD) (WISH) (SLDB) Higher; (ODNS) (CPB) (CMTL) Lower (more...)
Jun 8, 2021 05:54PM
Jun 8, 2021 04:01PM
Jun 8, 2021 04:01PM
Jun 8, 2021 07:34AM
Jun 8, 2021 07:30AM
May 5, 2021 06:21AM
May 4, 2021 08:00AM Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
May 4, 2021 07:59AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All